Stokkel MPM - Search Results

1

Predictive risk factors for sentinel lymph node nonvisualization on planar lymphoscintigraphy using an intratumoral injection in patients with primary breast cancer.

Hellingman D, Wan OY, de Wit-van der Veen BJ, van der Ploeg IM, Elkhuizen PHM, Rutgers EJT, Stokkel MPM. Hellingman D, et al. Among authors: stokkel mpm. Nucl Med Commun. 2019 Apr;40(4):317-324. doi: 10.1097/MNM.0000000000000971. Nucl Med Commun. 2019. PMID: 30601244

2

Unexpected brain uptake in radioimmunoscintigraphy using F(ab)2 monoclonal antibodies.

Stokkel MP, Hoefnagel CA, Rutgers EJ. Stokkel MP, et al. Clin Nucl Med. 1993 Aug;18(8):709-10. doi: 10.1097/00003072-199308000-00018. Clin Nucl Med. 1993. PMID: 8403707 No abstract available.

3

The value of pretreatment clinical and biochemical parameters in patients with newly diagnosed untreated prostate carcinoma and no indications for bone metastases on the bone scintigram.

Stokkel M, Zwinderman A, Zwartendijk J, Pauwels E, van Eck-Smit B. Stokkel M, et al. Eur J Nucl Med. 1997 Oct;24(10):1215-20. doi: 10.1007/s002590050144. Eur J Nucl Med. 1997. PMID: 9323261

4

Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.

Stokkel MP, ten Broek FW, van Rijk PP. Stokkel MP, et al. Eur J Nucl Med. 1999 May;26(5):499-503. doi: 10.1007/s002590050417. Eur J Nucl Med. 1999. PMID: 10382094

5

The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.

Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. Stokkel MP, et al. Eur J Nucl Med. 1999 Jul;26(7):767-73. doi: 10.1007/s002590050448. Eur J Nucl Med. 1999. PMID: 10398825

6

Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.

Stokkel M, Stevens H, Taphoorn M, Van Rijk P. Stokkel M, et al. Nucl Med Commun. 1999 May;20(5):411-7. Nucl Med Commun. 1999. PMID: 10404525

7

Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer.

Stokkel MP, Bakker PF, Heine R, Schlösser NJ, Lammers JW, Van Rijk PP. Stokkel MP, et al. Nucl Med Commun. 1999 Nov;20(11):1001-7. doi: 10.1097/00006231-199911000-00004. Nucl Med Commun. 1999. PMID: 10572909 Clinical Trial.

8

Myocardial perfusion scintigraphy with adenosine: does it impair the left ventricular ejection fraction obtained with gated SPECT?

Brinkman N, Dibbets-Schneider P, Scholte AJ, Stokkel MP. Brinkman N, et al. Clin Nucl Med. 2008 Feb;33(2):89-93. doi: 10.1097/RLU.0b013e31815f2454. Clin Nucl Med. 2008. PMID: 18209525

9

The value of I-131 SPECT in the detection of recurrent differentiated thyroid cancer.

Geerlings JA, van Zuijlen A, Lohmann EM, Smit JW, Stokkel MP. Geerlings JA, et al. Nucl Med Commun. 2010 May;31(5):417-22. doi: 10.1097/MNM.0b013e3283375762. Nucl Med Commun. 2010. PMID: 20154638

10

Mathematical methods to determine quantitative parameters of myocardial 123I-MIBG studies: a review of the literature.

van der Veen L, Scholte A, Stokkel M. van der Veen L, et al. Nucl Med Commun. 2010 Jul;31(7):617-28. doi: 10.1097/MNM.0b013e328337a99b. Nucl Med Commun. 2010. PMID: 20220545 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters